The object of the IASON project is the development of a system which is characterized by combining 

  • Diagnosing Alzheimer's disease at a (preclinical) stage of its development, when no symptoms are yet manifest,
  • Supporting Alzheimer's patients with an “Intelligent Emotionally Empathic Digital Assistant (IEEDA)” in their practical everyday life, see the corresponding article on,
  • and supporting the therapy of Alzheimer's patients by a novel approach, gamma entrainment, the effectiveness of which has been demonstrated in a mouse model by scientists from the Picower Institute and the Singer Lab,

For further information, see